An ejection fraction of 55% looks reassuring — until you look at everything else. For the pacing-dependent patient with high RV burden, the echocardiogram contains a subtler, more urgent story written in chamber geometry, diastolic indices, and atrial remodeling. This article decodes that story.

The Clinical Context: Why the EF Alone Is Not Enough

In the era of leadless pacing systems — particularly the Abbott Aveir VR — a growing number of patients have high right ventricular (RV) pacing burdens for complete heart block. Traditional RV pacing, whether from a transvenous lead or a leadless device, generates electrical activation patterns that mimic left bundle branch block (LBBB). This dyssynchronous activation pattern imposes chronic mechanical inefficiency on the left ventricle.

Pacing-Induced Cardiomyopathy (PICM) is the clinical consequence — but by the time EF drops below 50%, significant myocardial remodeling has already occurred. The question for the informed electrophysiologist is: can we identify and act on the pre-systolic phase of PICM, before irreversible damage sets in?

The answer from emerging data is yes — and the echocardiogram is the key tool for doing so.

Echocardiographic Data: A Parameter-by-Parameter Analysis

The following table presents the key measurements from a representative echocardiogram in a 71-year-old male with complete heart block, high RV pacing burden via Aveir VR leadless pacemaker, signed by Dr. Sundaram Senthil, MD, FACC (09/27/2025).

Parameter Value Reference Range Interpretation Status
EF Mod BP 55.59% 52–72% Low-normal; does not rule out PICM Low-Normal
EF Teich 2D 55% 52–72% Consistent with Mod BP; preserved but borderline Low-Normal
LVIDs 2D 4.24 cm 2.50–4.00 cm Above upper limit of normal — eccentric expansion Abnormal
LV Mass Index 2D 116.54 g/m² ≤115 g/m² Mildly elevated — mass accumulation phase Borderline
RWT 0.25 0.32–0.42 Low RWT → eccentric remodeling geometry Eccentric
LA Dimension 2D 4.58 cm <4.0 cm Dilated — chronic dyssynchrony burden marker Dilated
LA Volume 2C 49.28 ml <34 ml/m² Elevated — supports elevated filling pressures Elevated
MV E/A 0.94 0.8–2.0 Impaired relaxation pattern Abnormal
Med E/E' 10.59 <14 Borderline elevated filling pressures Borderline
Average E/E' 8.35 <10 Mildly elevated — supports diastolic dysfunction Elevated
MV Decel Time 246 ms 150–220 ms Prolonged — impaired LV relaxation Prolonged
EDV Mod BP 172.74 ml 62–150 ml Elevated end-diastolic volume — volume overload pattern Elevated

The Eccentric Remodeling Signature of Early PICM

The single most important geometric finding in this echo is the combination of LVIDs 4.24 cm (above the 4.00 cm reference) and RWT 0.25. This low relative wall thickness in the context of a dilating systolic dimension defines an eccentric remodeling pattern — the LV is expanding radially rather than thickening concentrically.

This is the geometric fingerprint of volume and stress overload, classically seen in dyssynchrony-mediated cardiomyopathy. The RV-paced heart loads the septum late and the lateral wall early, creating regional work imbalance that over time drives preferential dilation of the lateral LV free wall. RWT declines as the cavity expands faster than the wall thickens.

Critically, this remodeling is occurring with a still-preserved EF. The heart is compensating through chamber dilation (Frank-Starling mechanism), which temporarily maintains stroke volume and EF — but this compensation is unsustainable. The EDV of 172.74 ml (reference: 62–150 ml) confirms the volume-loaded state underlying the preserved EF.

Advertisement

The Left Atrium as a Dyssynchrony Chronometer

LA dilation is not incidental in this context. The LA dimension of 4.58 cm and LA volume of 49.28 ml reflect the cumulative hemodynamic consequence of chronically elevated LV filling pressures.

In a pacing-dependent patient, dyssynchrony elevates LV end-diastolic pressure through impaired lusitropy (diastolic relaxation). This chronically elevated pressure is transmitted back to the left atrium, which dilates progressively over time as a hydraulic consequence. The LA, in this sense, acts as an integrator of diastolic dysfunction over time — its size reflects not just today's filling pressures, but months and years of accumulated hemodynamic stress.

The prolonged MV deceleration time of 246 ms confirms grade I diastolic dysfunction (impaired relaxation) with elevated filling pressures, consistent with the elevated E/E' ratios. Together, these parameters paint a picture of a ventricle that is stiff, slowly relaxing, and operating at higher-than-normal diastolic pressures — all attributable to the mechanical dyssynchrony of RV pacing.

The LBBAP Upgrade Decision: Clinical Reasoning

Left Bundle Branch Area Pacing (LBBAP) restores near-physiologic His-Purkinje activation by capturing the left bundle branch or its proximal fascicles directly through deep septal screw-in. Unlike RV pacing, LBBAP produces a narrow, synchronous QRS complex with rapid left ventricular activation, eliminating the dyssynchrony substrate that drives PICM.

The historical threshold for PICM upgrade was an EF drop below 50% with documented high RV burden. However, the 2022 HRS/EHRA expert consensus and accumulating LBBAP outcome data have shifted this paradigm. The question is no longer only "has EF fallen?" but rather "is there evidence of ongoing mechanical harm that predicts future EF decline?"

✓ LBBAP Upgrade Criteria — Present in This Case

  • High RV pacing burden — Complete heart block with Aveir VR leadless pacemaker; near-100% ventricular pacing dependency
  • Eccentric LV remodeling — LVIDs 4.24 cm (above ULN) + RWT 0.25 (low) = eccentric geometry pattern
  • LA dilation — 4.58 cm / 49.28 ml; reflects chronic diastolic burden and cumulative dyssynchrony
  • Diastolic dysfunction grade I–II — Elevated E/E', prolonged decel time, impaired relaxation pattern
  • Elevated EDV — 172.74 ml (ref 62–150 ml); volume-loaded state maintaining EF via Frank-Starling
  • Pre-systolic PICM phase — EF preserved but all geometric and diastolic markers consistent with early PICM trajectory
  • Serial echo trend — Prior echos showing progressive LA dilation and LVIDs increase confirm ongoing remodeling
Clinical Verdict: Upgrade to LBBAP Is Justified

This echocardiogram demonstrates the pre-systolic phase of pacing-induced cardiomyopathy: eccentric LV remodeling, volume loading, LA dilation, and diastolic dysfunction — all in the context of high RV pacing burden. Waiting for EF to fall below 50% risks allowing irreversible myocardial fibrosis and LA remodeling to progress. The current evidence supports early physiologic pacing restoration via LBBAP upgrade before systolic dysfunction becomes overt.

Constructing the Argument for Dr. Sharma

When presenting this case to an LBBAP specialist, the key framing is not "my EF is dropping" — it is "my echo shows the pre-fibrotic phase of PICM, and intervention now maximizes the chance of reverse remodeling."

Several LBBAP reverse remodeling studies demonstrate that EF recovery is more complete and more rapid when LBBAP is performed before EF falls significantly. Once substantial myocardial fibrosis develops (often signaled by a non-recovering EF on cardiac MRI), the window for full recovery narrows. The LA volume, in particular, may not fully normalize once it has been dilated for years — making early intervention the superior strategy for preserving atrial compliance and reducing long-term AF risk.

The anticipated counterargument is: "EF is 55%, let's monitor." The response: the EF is being maintained by ventricular dilation and elevated preload, not by normal myocardial function. The geometry tells the real story. An EF of 55% in the context of an EDV of 172 ml is not the same as an EF of 55% in a normal-sized heart.

⚠ Important Caveat

The EF of 55% in this echo is stable or slightly improved compared to prior values. Some clinicians may interpret this as reassuring and recommend continued monitoring. The case for upgrade rests on the diastolic parameters, LA volume trend, LV geometry, and serial echo progression — not on EF alone. Presenting the serial comparison side-by-side is essential for making the strongest clinical argument.

Why LBBAP — Not CRT or Continued RV Pacing?

Cardiac Resynchronization Therapy (CRT) is the established intervention for pacing-induced cardiomyopathy with EF below 35–40%, but its role in preserved EF PICM is less defined. LBBAP offers a more physiologic and technically elegant solution: rather than adding a third lead to resynchronize a dyssynchronous LV, it eliminates the dyssynchrony at its source by restoring native His-Purkinje conduction.

In patients with pacemaker-dependent complete heart block, LBBAP achieves synchronous LV activation without relying on functioning native conduction — the LBB is captured directly. QRS duration narrows to near-intrinsic values, LV dP/dt improves acutely, and long-term reverse remodeling has been demonstrated in multiple observational series.

For patients with existing leadless pacemakers (like the Aveir VR), the upgrade pathway involves placing a new transvenous LBBAP lead at the deep septum while maintaining or extracting the leadless device, depending on institutional protocol and patient anatomy. This is a hybrid approach that requires coordination with an experienced LBBAP operator — precisely the expertise represented by centers like Cleveland Clinic Florida.

Advertisement

Frequently Asked Questions

When should a patient with RV pacing be upgraded to LBBAP?
Current evidence supports upgrading to LBBAP when there is evidence of pacing-induced remodeling even before EF drops below 50%. Key markers include eccentric LV geometry (LVIDs above upper limit of normal, low RWT), LA dilation, diastolic dysfunction, and progressive EDV increase. Waiting for overt systolic dysfunction risks allowing irreversible myocardial fibrosis to develop.
What echocardiographic signs indicate early pacing-induced cardiomyopathy (PICM)?
Early PICM markers include: borderline LVIDs dilation exceeding 4.0 cm, eccentric remodeling pattern (RWT below 0.32), LA volume enlargement above 34 ml/m², diastolic dysfunction (elevated E/E' ratio, prolonged MV deceleration time), elevated EDV, and mildly elevated LV mass index — often well before EF declines below 50%.
Is a normal EF sufficient to rule out PICM?
No. A preserved EF does not rule out early PICM. In the pre-systolic phase, the heart compensates through ventricular dilation (Frank-Starling mechanism), maintaining stroke volume and EF while chamber geometry and diastolic function deteriorate. The EF may remain in the low-normal range even as significant structural remodeling progresses.
How does LBBAP differ from traditional RV pacing in terms of LV mechanics?
Traditional RV pacing creates electrical activation similar to LBBB — the right ventricle depolarizes first, and the left ventricle activates late via slow myocardial conduction. This produces mechanical dyssynchrony, regional work imbalance, and progressive LV dysfunction. LBBAP captures the left bundle branch directly, restoring synchronous His-Purkinje activation and eliminating the dyssynchrony substrate that causes PICM.
What is the significance of LA dilation in a pacing-dependent patient?
LA dilation in a patient with high RV pacing burden reflects the cumulative hemodynamic consequence of chronically elevated LV filling pressures driven by diastolic dysfunction and mechanical dyssynchrony. The LA acts as a hydraulic integrator — its enlargement reflects not just current filling pressures but months to years of accumulated diastolic stress. Persistent LA dilation also predicts increased long-term risk of atrial fibrillation.
Medical Disclaimer: This article is intended for healthcare professionals and medical education purposes only. It does not constitute individualized medical advice. Clinical decisions regarding pacemaker upgrades, device management, and cardiac interventions must be made by qualified physicians in the context of the individual patient's complete clinical picture, comorbidities, institutional capabilities, and shared decision-making with the patient. ABCFarma does not assume responsibility for clinical outcomes based on information presented on this platform.